Literature DB >> 17981630

The effects of illicit drugs on the HIV infected brain.

Iain Crawford Anthony1, Juan-Carlos Arango, Ben Stephens, Peter Simmonds, Jeanne Elisabeth Bell.   

Abstract

Evidence accumulating from clinical observations, neuroimaging and neuropathological studies suggests that illicit drug abuse accentuates the adverse effects of HIV on the central nervous system (CNS). Experimental investigation in cell culture models supports this conclusion. Injecting drug abuse is also a risk factor for the acquisition of HIV infection, the incidence of which continues to rise in intravenous drug users (IVDU) even in countries with access to effective therapy. In order to understand the interactions of drug abuse and HIV infection, it is necessary to examine the effects of each insult in isolation before looking for their combined effects. This review traces progress in understanding the pathogenesis of HIV related CNS disorders before the introduction of effective therapy and compares the state of our knowledge now that effective therapy has significantly modified disease progression. The additional impact of intravenous drug abuse on HIV-associated brain disease, then and now, is also reviewed. Predictions for the future are discussed, based on what is known at present and on recently emerging data.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981630     DOI: 10.2741/2762

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  46 in total

Review 1.  Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.

Authors:  Suman Jayadev; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-17       Impact factor: 4.147

2.  Chronic SIV and morphine treatment increases heat shock protein 5 expression at the synapse.

Authors:  Gurudutt Pendyala; Palsamy Periyasamy; Shannon Callen; Howard S Fox; Steven J Lisco; Shilpa J Buch
Journal:  J Neurovirol       Date:  2015-06-03       Impact factor: 2.643

3.  Neurocognitive impact of substance use in HIV infection.

Authors:  Desiree A Byrd; Robert P Fellows; Susan Morgello; Donald Franklin; Robert K Heaton; Reena Deutsch; J Hampton Atkinson; David B Clifford; Ann C Collier; Christina M Marra; Benjamin Gelman; J Allen McCutchan; Nichole A Duarte; David M Simpson; Justin McArthur; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

Review 4.  Substance abuse, HIV-1 and hepatitis.

Authors:  Nirzari Parikh; Michael R Nonnemacher; Vanessa Pirrone; Timothy Block; Anand Mehta; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2012-10       Impact factor: 1.581

5.  Morphine modulation of toll-like receptors in microglial cells potentiates neuropathogenesis in a HIV-1 model of coinfection with pneumococcal pneumoniae.

Authors:  Raini Dutta; Anitha Krishnan; Jingjing Meng; Subash Das; Jing Ma; Santanu Banerjee; Jinghua Wang; Richard Charboneau; Om Prakash; Roderick A Barke; Sabita Roy
Journal:  J Neurosci       Date:  2012-07-18       Impact factor: 6.167

Review 6.  Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.

Authors:  Christopher Kent Arnatt; Yan Zhang
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

7.  Productive infection of human neural progenitor cells by R5 tropic HIV-1: opiate co-exposure heightens infectivity and functional vulnerability.

Authors:  Joyce M Balinang; Ruturaj R Masvekar; Kurt F Hauser; Pamela E Knapp
Journal:  AIDS       Date:  2017-03-27       Impact factor: 4.177

Review 8.  Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Authors:  Virawudh Soontornniyomkij; James P Kesby; Erin E Morgan; Amanda Bischoff-Grethe; Arpi Minassian; Gregory G Brown; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-02       Impact factor: 4.147

9.  Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals.

Authors:  Seth M Dever; Blair N Costin; Ruqiang Xu; Nazira El-Hage; Joyce Balinang; Alexander Samoshkin; Megan A O'Brien; Marypeace McRae; Luda Diatchenko; Pamela E Knapp; Kurt F Hauser
Journal:  AIDS       Date:  2014-01-02       Impact factor: 4.177

10.  Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120.

Authors:  Valeriya Avdoshina; Francesca Biggio; Guillermo Palchik; Lee A Campbell; Italo Mocchetti
Journal:  Glia       Date:  2010-10       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.